Mode
Text Size
Log in / Sign up
Phase 4 N=2,776 Randomized Diagnostic

Study of Tomography of Nephrolithiasis Evaluation

Urolithiasis

Enrolled (actual)
2,776
Serious AEs
0.4%
Results posted
Dec 2014
Primary outcome: Primary: High Risk Diagnosis With Complication — 6; 3; 2 participants

Study Design & Population

Study type
Interventional
Phase
Phase 4
Interventions
Point-of-care Ultrasound (Other); Radiology Ultrasound (Radiation); Radiology CT (Other)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
University of California, San Francisco
Primary completion
Sep 2013

Outcome Measures

OutcomeResultp-value
PRIMARY
High Risk Diagnosis With Complication
6; 3; 2
PRIMARY
Cumulative Radiation Exposure
10.1; 9.3; 17.2
SECONDARY
ED Length of Stay
5.1; 6.4; 6.3
SECONDARY
Return Visits to ED or Hospital
231; 231; 255; 87; 84; 83
SECONDARY
Accuracy for Stones by Arm
85; 84; 86; 50; 53; 53

Summary

This is a multi-center, randomized controlled trial of ultrasonography (ultrasound) compared to computed tomography (CT) for the initial emergency room evaluation of patients with suspected renal colic. The investigators will compare several measures of effectiveness including morbidity related to the patient's underlying disease, or complications related to delayed diagnosis, patient status regarding pain/missed days of work, and utilization of health care resources based on one of three study arms: ultrasound in the Emergency Department, ultrasound in Radiology or CT.

Eligibility Criteria

Inclusion Criteria

  • men or women = or >18 but or = 76 years old
  • pregnancy or planning pregnancy
  • Morbid obesity (>285 pounds in men, >250 pounds in women)
  • patients with an acute abdomen, signs of sepsis, signs of alternate diagnosis (ie appendicitis, abdominal aortic aneurysm, pyelonephritis, kidney stones not suspected).
  • history of kidney problems (hemodialysis, kidney transplant, presence of only one kidney)
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01451931). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search